Results 171 to 180 of about 38,660 (297)

Emerging Frontiers in Food Allergy Treatment: Progress, Challenges, and Prospects

Food Frontiers, EarlyView.
Food allergy is a rising global health concern with limited treatment options beyond allergen avoidance and emergency care. This review explores the evolving therapeutic landscape, highlighting advances in allergen immunotherapy, biologics such as monoclonal antibodies, and emerging vaccine‐based approaches.
Ayesha Zahid, Hazrat Ismail, Madiha Ajaz, Abdul Qadeer   +3 more
wiley   +1 more source

Chimeric RNA isoforms generated by diverse mechanisms from two C-type lectins modulate innate immunity in arthropods. [PDF]

Proc Natl Acad Sci U S A
Huang Y, Huang X, Zhang LH, Ren Q.
europepmc   +1 more source

Preferential Induction of CD4+ T Cell Responses through In Vivo Targeting of Antigen to Dendritic Cell-Associated C-Type Lectin-1 [PDF]

, 2006
Robert W. Carter, Clare Thompson, Delyth M. Reid, Simon Y. C. Wong, David F. Tough   +4 more
openalex   +1 more source

Comparative Transcriptome Analysis Reveals Epithelial Growth Factor Receptor (EGFR) Pathway and Secreted C-Type Lectins as Essential Drivers of Leg Regeneration in <i>Periplaneta americana</i>. [PDF]

Insects
Liu X, Sun N, Wu X, Wu J, Xian S, Wang D, Pei Y.   +6 more
europepmc   +1 more source

Molecular cloning and characterization of a C-type lectin from Ancylostoma ceylanicum: Evidence for a role in hookworm reproductive physiology [PDF]

, 2006
Allison C. Brown, Lisa M. Harrison, Wadim J Kapulkin, Brian F. Jones, Anindita Sinha, Amy F. Savage, Nicholas Villalon, Michael Cappello   +7 more
openalex   +1 more source

Synthesis of a multivalent α-1,2-mannobiose ligand for targeting C-type lectins. [PDF]

RSC Adv
Langer J, Hartmann L, Snyder NL.
europepmc   +1 more source

The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose [PDF]

, 2006
Eamon P. McGreal, Marcela Rosas, Gordon D. Brown, Susanne Zamze, Simon Y. C. Wong, Siamon Gordon, Luisa Martı́nez-Pomares, Philip R. Taylor   +7 more
openalex   +1 more source

Integrated scFv identification and CAR T cell generation for AML targeting in vivo

International Journal of Cancer, EarlyView.
What's New? Acute myeloid leukemia (AML) is a rapidly progressing blood cancer. Advancing chimeric antigen receptor (CAR) T cell therapies, particularly through rapid translation of single chain variable fragment (scFv) discovery into CAR constructs, may improve clinical outcomes, especially the development of patient individualized CAR T cells.
Yi Liu, Annika Lauk, David Sedloev, Josephine Brysting, Ela Cetin, Chunan Liu, Maximilian Mönnig, Thomas Luft, Haiyang Yun, Michael Schmitt, Tim Sauer, Fengbiao Zhou, Christian Rohde, Carsten Müller‐Tidow   +13 more
wiley   +1 more source

Group XIV C-type lectins: emerging targets in tumor angiogenesis. [PDF]

Angiogenesis
Yee EJ, Vigil I, Sun Y, Torphy RJ, Schulick RD, Zhu Y.   +5 more
europepmc   +1 more source

Targeting the ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti‐VEGF resistance in endometrial cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate the role of ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) in endometrial cancer (EC) progression and its potential as a therapeutic target to enhance the efficacy of antiangiogenic treatment. Methods ST3Gal1 expression and its clinical relevance were analyzed in EC tissues.
Chia‐Hao Liu, Szu‐Ting Yang, Wei‐Ting Chao, Chen‐Hao Lin, Yu‐Chieh Lee, Chiung‐Ru Lai, Shie‐Liang Hsieh, Liang‐Wei Wang, Peng‐Hui Wang   +8 more
wiley   +1 more source